Blood cancers
Acute myeloid and lymphoblastic leukaemia, chronic myeloid leukaemia, Hodgkin and non-Hodgkin lymphoma, multiple myeloma and myelodysplastic syndromes.
Explore leading hospitals in India with 1,000+ patients successfully treated, experienced transplant teams and support from consultation to recovery.
No charge for the opinion. You pay the hospital directly.
Figure. A single self-renewing stem cell gives rise, through progenitor stages, to every cell in the blood.
Bone marrow is the tissue inside your bones where blood is manufactured. Every red cell, white cell and platelet in circulation began there, as a single haematopoietic stem cell.
Marrow fails in one of three ways: it produces the wrong cells, as in leukaemia; it produces faulty cells, as in thalassaemia major and sickle cell disease; or it stops producing, as in aplastic anaemia. A transplant addresses all three by replacing the stem cell population itself, which is why it can be curative rather than suppressive.
Send the reports. A transplant physician will tell you plainly, at no charge.
Acute myeloid and lymphoblastic leukaemia, chronic myeloid leukaemia, Hodgkin and non-Hodgkin lymphoma, multiple myeloma and myelodysplastic syndromes.
Thalassaemia major, sickle cell disease, Fanconi anaemia and Diamond–Blackfan anaemia — where a transplant is currently the only established cure.
Severe aplastic anaemia, pure red cell aplasia and paroxysmal nocturnal haemoglobinuria.
Severe combined immunodeficiency, Wiskott–Aldrich syndrome, Hurler syndrome and adrenoleukodystrophy.
A senior haemato-oncologist reviews the diagnosis and recent investigations, then tells you whether a transplant is indicated, which type would apply, what it would cost and how soon it could begin.
What to send: confirmed diagnosis and date, most recent complete blood count, bone marrow aspirate and biopsy report, cytogenetic or molecular results, summary of treatment so far, HLA typing if performed, patient age and weight. Clear photographs of printed reports are fine.
Where the stem cells come from determines the transplant type, the risk profile and much of the cost.
| Type | Graft source | GVHD risk | Indicative cost |
|---|---|---|---|
| Autologous | The patient's own cells, cryopreserved | None | $30,000–50,000 |
| Allogeneic | HLA-matched sibling or registry donor | Moderate | $40,000–60,000 |
| Haploidentical | Half-matched parent, child or sibling | Higher, manageable | $50,000–70,000 |
| Cord blood | Banked umbilical cord unit | Lower for the degree of mismatch | $50,000–70,000 |
Indicative published ranges for allogeneic transplantation, scaled against the upper United States figure. Verify against current hospital tariffs before relying on them.
Between USD 16,000 and USD 50,000 for most patients, depending on transplant type, diagnosis, donor availability and hospital — a fraction of the equivalent in the United States, Europe or Singapore, using the same international protocols.
Staffing, facilities and overheads across the whole healthcare system are a fraction of Western equivalents.
India is among the world's largest producers of generic chemotherapy and supportive-care drugs, made domestically.
High-volume transplant programmes spread fixed costs across many patients and build deep team experience.
Several thousand stem cell transplants are performed in India each year across a network of dedicated units. International patients are not queued behind domestic demand.
JCI and NABH transplant wards with HEPA filtration, positive pressure and continuous intensivist cover.
Complex adult and paediatric cases are routine rather than exceptional.
Visa letters, transfers, interpreters and long-stay accommodation for attendants.
Saket & Patparganj · Delhi NCR
Noida & Gurugram · Delhi NCR
Delhi · Chennai · Hyderabad
Gurugram · Delhi NCR
For most patients the cost falls between USD 16,000 and USD 50,000. An autologous transplant is typically quoted at USD 30,000–50,000, an allogeneic transplant at USD 40,000–60,000, and haploidentical or cord blood transplants at USD 50,000–70,000. The final figure depends on the diagnosis, the transplant type, donor availability, the hospital and whether complications occur.
Plan for approximately 90 days. That covers 7 to 10 days of pre-transplant work-up, around 21 days as an inpatient in the transplant ward, and then outpatient monitoring near the hospital until the transplant team confirms your counts are stable and it is safe to fly.
A haploidentical transplant from a half-matched relative is well established in India and performed in high volume there. Because every biological parent and child shares exactly half the HLA markers, almost every patient with a living close relative has a possible donor. Registry and cord blood searches are also possible.
There is no single success rate. Outcome depends heavily on the diagnosis, the disease status at transplant, the degree of HLA match, the patient's age and organ function, and the centre's experience with that indication. Children transplanted for thalassaemia major with a matched sibling donor before significant iron overload have among the best outcomes of any indication, while leukaemia transplanted after relapse does considerably worse than the same disease transplanted in first remission. Ask your transplant physician for the expected outcome in your specific case.
The hospital issues an invitation letter confirming the diagnosis, the planned treatment and the estimated duration. You submit that with your passport, financial proof and medical reports to the Indian mission in your country. Attendants apply separately for medical attendant visas linked to the patient's visa.
No. There is no charge for the medical opinion, the cost estimate or travel coordination. You pay the hospital directly for your treatment.
Send the diagnosis and recent investigations. A transplant physician in India will advise whether transplantation is indicated, which type would apply, what it would cost and how soon it could begin.
Confirmed diagnosis and date · most recent complete blood count · bone marrow aspirate and biopsy report · cytogenetic or molecular results · summary of treatment so far · HLA typing if performed · patient age and weight. Clear photographs of printed reports are fine; they need no translation or certification.
Leave any field blank if the information is not available.